HOME › Press Releases › eClinical solutions Market worth 5.98 Billion USD by 2020
eClinical solutions Market worth 5.98 Billion USD by 2020
The report “eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (Web Hosted, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2020”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Browse 70 market data Tables and 49 Figures spread through 160 Pages and in-depth TOC on "eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (Web Hosted, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
This report studies the eClinical solutions market over the forecast period of 2015 to 2020. The market is expected to reach USD 5.98 Billion by 2020, at CAGR of 12.1% from 2015 to 2020.
Based on type of product, the global eClinical solutions market is divided into nine segments, namely, electronic data capture (EDC) and clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platform, randomization & trial supply management systems (RTMS), clinical data integration platforms, electronic clinical outcome assessment (eCOA), safety solutions, electronic trail master files (eTMF), and others (regulatory information management solutions, coding systems, and core laboratory integration solutions). The eClinical solutions market has also been segmented on the basis of delivery mode into web-hosted (On-demand), licensed enterprise (On-premise), and cloud-based (SaaS) solutions. Bases on clinical trial phase, the market is divided into four segments phase I, phase II, phase II, and phase IV. On the basis of end user, the global eClinical solutions market has been segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions.
A number of factors such as growing adoption of software solutions during clinical research and trials, increasing R&D expenditure by pharmaceutical and biopharmaceutical companies, growing government funding to support clinical trials, and rising number of life science companies and CROs are propelling the growth of the eClinical solutions market. In addition, increasing clinical research in emerging Asian countries, increasing outsourcing of clinical trials to CROs, and developments of cost effective modules are offering high growth opportunities for market players. On the other hand, high implementation cost, dearth of skilled research professionals, and lack of awareness of clinical data sciences software in research community are restricting the growth of the global eClinical solutions market.
North America is estimated to be the largest regional segment in the global eClinical solutions market in 2015, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 16.1% from 2015 to 2020. A number of factors, including increasing government funding to support clinical trials, presence of less stringent regulatory guidelines compare to developed nations to conduct clinical trials, availability of large patient base and faster patient recruitment for clinical trial, and growing number of pharmaceutical companies and CROs are stimulating the growth of the eClinical solutions market in the Asia-Pacific region.
Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.) PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), eClinical Solutions, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S.) are some key players operating in the global eClinical solutions market.
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India